Digital Hypnotic CBT Program to Reduce Depression in Adults with “Long-COVID”
Michael Yapko, Ph.D.; Eva Szigethy, MD, PhD
Individuals with post-acute sequelae of SARS-CoV-2 (PASC) suffer diverse and often idiosyncratic symptom profiles that challenge the medical community. The psychological toll can be particularly challenging in the absence of clear diagnosis and well-established treatments. Hopelessness and helplessness can easily fuel high levels of depression and anxiety, further aggravating suffering on all levels. Both hypnosis and cognitive behavioral therapy (CBT) have been shown to reduce depression, cognitive fog and sleep, which are common symptoms for these patients. This workshop will review how hypnosis can enhance CBT and evaluate the efficacy of this combined modality on behavioral manifestations of SARS-CoV-2.
APPROVED ASCH CE: 1.5
APPROVED CME: 1.5
ORIG RELEASE DATE: March 2022
EXPIRATION DATE: December 2025